1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE INDUSTRY SERVICES
  4. PSYCHEMEDICS CORP.

Psychemedics Corp.

XNAS: PMDI

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Psychemedics Corp. is on 28 Mar 2025 for the purpose of Psychemedics Corp Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Psychemedics Corp.

The latest disclosure was made by Peter H. Kamin in Psychemedics Corp. where a trade of 320,708 Common Stock, $0.005 Par Value done at an average price of $2.4 was reported to US exchanges on Dec. 10, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Peter H. Kamin Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 2.35 per share. 10 Dec 2024 320,708 1,499,710 (27%) 5% 2.4 753,664 Common Stock, $0.005 Par Value
Peter H. Kamin Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.35 per share. 03 Dec 2024 1,409,712 1,820,418 (32%) 25% 2.3 3,312,823 Common Stock, $0.005 Par Value
Brian Hullinger Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 100,000 100,000 - - Stock Option (Right to Buy)
Brian Hullinger Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 200,000 200,000 - - Stock Option (Right to Buy)
Michael Weisenhoff Assistant Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 4,000 4,000 (0%) 0% 0 Common Stock, $.005 Par Value
Darius G. Nevin Director, See Footnote 1 Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 14,000 23,000 (0%) 0% 0 Common Stock, $.005 Par Value
Andrew M. Reynolds Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 14,000 28,000 (0%) 0% 0 Common Stock, $.005 Par Value
Peter H. Kamin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 14,000 237,031 (4%) 0% 0 Common Stock, $.005 Par Value
Robyn C Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 14,000 39,000 (0%) 0% 0 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Sale of securities on an exchange or to another person at price $ 4.66 per share. 17 Aug 2023 12,700 23,250 (0%) 0% 4.7 59,182 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.93 per share. 22 May 2023 375 36,489 (0%) 0% 4.9 1,849 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.93 per share. 22 May 2023 1,500 246,737 (4%) 0% 4.9 7,395 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.93 per share. 22 May 2023 825 35,950 (0%) 0% 4.9 4,067 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. 15 May 2023 337 36,864 (0%) 0% 4.9 1,641 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. 15 May 2023 1,725 248,237 (4%) 0% 4.9 8,401 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. 15 May 2023 900 36,775 (0%) 0% 4.9 4,383 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Purchase of securities on an exchange or from another person at price $ 4.95 per share. 16 Dec 2022 100 37,201 (0%) 0% 5.0 495 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.18 per share. 11 Nov 2022 525 37,101 (0%) 0% 6.2 3,245 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.18 per share. 11 Nov 2022 2,625 249,962 (4%) 0% 6.2 16,223 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.18 per share. 11 Nov 2022 1,350 37,675 (0%) 0% 6.2 8,343 Common Stock, $.005 Par Value
Darius G. Nevin Director, See Footnote 1 Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 9,000 9,000 (0%) 0% 0 Common Stock, $.005 Par Value
Peter H. Kamin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 9,000 223,031 (4%) 0% 0 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 5,000 37,626 (0%) 0% 0 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 20,000 252,587 (4%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 12,000 71,583 (1%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 12,000 74,399 (1%) 0% 0 Common Stock, $.005 Par Value
Andrew M. Reynolds Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 12,000 14,000 (0%) 0% 0 Common Stock, $.005 Par Value
Robyn C Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 12,000 25,000 (0%) 0% 0 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 11,000 39,025 (0%) 0% 0 Common Stock, $.005 Par Value
Andrew Limbek Vice President & Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 7,000 13,863 (0%) 0% 0 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. 13 May 2022 337 32,626 (0%) 0% 6.4 2,170 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. 13 May 2022 1,725 232,587 (4%) 0% 6.4 11,109 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. 13 May 2022 900 28,025 (0%) 0% 6.4 5,796 Common Stock, $.005 Par Value
Andrew Limbek Vice President & Controller Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. 13 May 2022 600 6,863 (0%) 0% 6.4 3,864 Common Stock, $.005 Par Value
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.52 per share. 19 Apr 2022 15,152 143,190 (2%) 0% 6.5 98,791 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.52 per share. 19 Apr 2022 11,706 216,778 (3%) 0% 6.5 76,323 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.52 per share. 19 Apr 2022 627 43,180 (0%) 0% 6.5 4,088 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.72 per share. 19 Apr 2022 8,100 214,031 (3%) 0% 6.7 54,432 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.72 per share. 19 Apr 2022 1,950 218,728 (3%) 0% 6.7 13,104 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.72 per share. 19 Apr 2022 3,808 146,998 (2%) 0% 6.7 25,590 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.72 per share. 19 Apr 2022 1,800 44,980 (0%) 0% 6.7 12,096 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.79 per share. 07 Apr 2022 4,000 205,072 (3%) 0% 6.8 27,160 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.68 per share. 07 Apr 2022 3,000 201,072 (3%) 0% 6.7 20,040 Common Stock
Fred J. Weinert Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2022 1,000 1,000 - - Stock Option (Right to Buy)
Fred J. Weinert Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.07 per share. 05 Apr 2022 1,000 59,583 (1%) 0% 4.1 4,070 Common Stock, $.005 Par Value
Andrew M. Reynolds Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 2,000 2,000 (0%) 0% 0 Common Stock, $.005 Par Value
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.88 per share. 30 Mar 2022 7,814 123,449 (2%) 0% 6.9 53,760 Common Stock
Peter H. Kamin Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.92 per share. 30 Mar 2022 4,589 128,038 (2%) 0% 6.9 31,756 Common Stock
Andrew Limbek Vice President & Controller Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.38 per share. 25 Jan 2022 37 7,463 (0%) 0% 7.4 273 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.50 per share. 12 Nov 2021 612 32,883 (0%) 0% 8.5 5,202 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.50 per share. 12 Nov 2021 3,062 234,312 (4%) 0% 8.5 26,027 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.50 per share. 12 Nov 2021 1,575 28,925 (0%) 0% 8.5 13,388 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 4,500 33,495 (0%) 0% 0 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 23,000 237,374 (4%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 11,000 58,583 (1%) 0% 0 Common Stock, $.005 Par Value
Harry F. Connick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 11,000 90,112 (1%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 11,000 62,399 (1%) 0% 0 Common Stock, $.005 Par Value
Robyn C Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 11,000 13,000 (0%) 0% 0 Common Stock, $.005 Par Value
Charles M. Doucot Executive Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 12,000 30,500 (0%) 0% 0 Common Stock, $.005 Par Value
Andrew Limbek Vice President & Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 6,000 7,500 (0%) 0% 0 Common Stock, $.005 Par Value
Robyn C Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2021 2,000 2,000 (0%) 0% 0 Common Stock, $.005 Par Value
Andrew Limbek Vice President & Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2021 1,500 1,500 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert Director Purchase of securities on an exchange or from another person at price $ 4.95 per share. 11 Dec 2020 1,000 111,381 (2%) 0% 5.0 4,950 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 5.00 per share. 08 Dec 2020 1,000 214,374 (3%) 0% 5 5,000 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Purchase of securities on an exchange or from another person at price $ 4.20 per share. 18 Nov 2020 500 26,669 (0%) 0% 4.2 2,100 Common Stock, $.005 Par Value
A. Clinton Allen Director Purchase of securities on an exchange or from another person at price $ 3.99 per share. 13 Nov 2020 2,000 3,000 (0%) 0% 4.0 7,980 Common Stock, $.005 Par Value
Fred J. Weinert Director Purchase of securities on an exchange or from another person at price $ 3.92 per share. 13 Nov 2020 2,000 110,381 (2%) 0% 3.9 7,840 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 3.93 per share. 12 Nov 2020 1,000 212,374 (3%) 0% 3.9 3,930 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 3.79 per share. 12 Nov 2020 1,000 213,374 (3%) 0% 3.8 3,790 Common Stock, $.005 Par Value
A. Clinton Allen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 2,000 2,000 - - Stock Option (Right to Buy)
A. Clinton Allen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 20,000 20,280 (0%) 0% 0 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 2,000 2,000 - - Stock Option (Right to Buy)
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 7,000 26,169 (0%) 0% 0 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 15,000 15,000 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 35,000 211,374 (3%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 20,000 47,583 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 2,000 2,000 - - Stock Option (Right to Buy)
Harry F. Connick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 2,000 2,000 - - Stock Option (Right to Buy)
Harry F. Connick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 20,000 79,112 (1%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 20,000 51,399 (0%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 2,000 2,000 - - Stock Option (Right to Buy)
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 3,000 3,000 - - Stock Option (Right to Buy)
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 10,000 25,866 (0%) 0% 0 Common Stock, $.005 Par Value
Charles M. Doucot Vice President Sales & Mktg Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 18,000 18,500 (0%) 0% 0 Common Stock, $.005 Par Value
Charles M. Doucot Vice President Sales & Mktg Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2020 7,000 7,000 - - Stock Option (Right to Buy)
A. Clinton Allen Director Gift of securities by or to the insider at price $ 0.00 per share. 01 Jun 2020 1,000 1,000 (0%) 0% 0 Common Stock, $.005 Par Value
A. Clinton Allen Director Gift of securities by or to the insider at price $ 0.00 per share. 01 Jun 2020 1,000 280 (0%) 0% 0 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.75 per share. 04 May 2020 399 15,866 (0%) 0% 5.7 2,294 Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 13 Dec 2019 1,000 27,583 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 13 Dec 2019 200 1,600 (0%) 0% 0 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 9.99 per share. 14 Jun 2019 1,000 176,374 (3%) 0% 10.0 9,990 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 9.84 per share. 12 Jun 2019 2,800 25,700 (0%) 0% 9.8 27,552 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 9.61 per share. 12 Jun 2019 3,900 19,169 (0%) 0% 9.6 37,479 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 9.82 per share. 12 Jun 2019 2,631 23,069 (0%) 0% 9.8 25,836 Common Stock, $.005 Par Value
A. Clinton Allen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 23,000 23,000 - - Stock Option (Right to Buy)
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 10,000 10,000 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 60,000 60,000 - - Stock Option ( Right to Buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 2,000 28,583 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 23,000 23,000 - - Stock Option (Right to Buy)
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 6,550 59,112 (1%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 23,000 23,000 - - Stock Option (Right to Buy)
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 3,500 16,419 (0%) 0% 0 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.60 per share. 03 May 2019 154 16,265 (0%) 0% 10.6 1,632 Common Stock, $.005 Par Value
Charles M. Doucot Vice President Sales & Mktg Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2019 30,000 30,000 - - Stock Option (Right-to-Buy)
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.60 per share. 30 Apr 2019 124 28,887 (0%) 0% 11.6 1,438 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.60 per share. 30 Apr 2019 1,051 175,374 (3%) 0% 11.6 12,192 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.60 per share. 30 Apr 2019 301 12,919 (0%) 0% 11.6 3,492 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Sale of securities on an exchange or to another person at price $ 15.11 per share. 11 Mar 2019 7,645 14,632 (0%) 0% 15.1 115,516 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Sale of securities on an exchange or to another person at price $ 15.06 per share. 11 Mar 2019 1,412 13,220 (0%) 0% 15.1 21,265 Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 11 Dec 2018 1,400 26,583 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 11 Dec 2018 600 1,400 (0%) 0% 0 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 19.23 per share. 06 Sep 2018 6,324 28,624 (0%) 0% 19.2 121,611 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Sale of securities on an exchange or to another person at price $ 19.99 per share. 21 May 2018 1,879 22,277 (0%) 0% 20.0 37,561 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Sale of securities on an exchange or to another person at price $ 20.14 per share. 21 May 2018 3,013 24,156 (0%) 0% 20.1 60,682 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.21 per share. 08 May 2018 323 34,508 (0%) 0% 20.2 6,528 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.21 per share. 08 May 2018 957 176,425 (3%) 0% 20.2 19,341 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.21 per share. 08 May 2018 282 27,169 (0%) 0% 20.2 5,699 Common Stock, $.005 Par Value
A. Clinton Allen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 12,500 12,500 - - Stock Option (Right to Buy)
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 5,000 5,000 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 28,000 28,000 - - Stock Option ( Right to Buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 12,500 12,500 - - Stock Option (Right to Buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 1,000 27,983 (0%) 0% 0 Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 3,400 52,562 (0%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 12,500 12,500 - - Stock Option (Right to Buy)
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 2,000 27,451 (0%) 0% 0 Common Stock, $.005 Par Value
Charles M. Doucot Vice President Sales & Mktg Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2018 18,000 18,000 - - Stock Option (Right-to-Buy)
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.06 per share. 30 Apr 2018 112 34,903 (0%) 0% 21.1 2,359 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.06 per share. 30 Apr 2018 846 177,382 (3%) 0% 21.1 17,817 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.06 per share. 30 Apr 2018 286 25,451 (0%) 0% 21.1 6,023 Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2017 1,000 26,983 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2017 200 400 (0%) 0% 0 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 16.88 per share. 14 Nov 2017 1,000 178,228 (3%) 0% 16.9 16,880 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 20.14 per share. 01 Sep 2017 2,167 34,706 (0%) 0% 20.1 43,643 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 20.37 per share. 01 Sep 2017 4,400 36,873 (0%) 0% 20.4 89,628 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 21.16 per share. 01 Sep 2017 981 41,273 (0%) 0% 21.2 20,758 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.04 per share. 23 May 2017 580 42,066 (0%) 0% 21.0 12,203 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.04 per share. 23 May 2017 1,344 177,228 (3%) 0% 21.0 28,278 Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.04 per share. 23 May 2017 689 19,781 (0%) 0% 21.0 14,497 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.04 per share. 23 May 2017 276 25,447 (0%) 0% 21.0 5,807 Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.51 per share. 12 May 2017 527 20,470 (0%) 0% 20.5 10,809 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 20.43 per share. 10 May 2017 3,000 42,447 (0%) 0% 20.4 61,290 Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.60 per share. 08 May 2017 384 45,447 (0%) 0% 20.6 7,910 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.60 per share. 08 May 2017 1,028 178,572 (3%) 0% 20.6 21,177 Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.60 per share. 08 May 2017 550 20,997 (0%) 0% 20.6 11,330 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.60 per share. 08 May 2017 284 25,642 (0%) 0% 20.6 5,850 Common Stock, $.005 Par Value
A. Clinton Allen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 14,000 14,000 - - Stock Option (Right to Buy)
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 8,000 8,000 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 40,000 40,000 - - Stock Option ( Right to Buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 1,000 27,983 (0%) 0% 0 Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 3,500 49,162 (0%) 0% 0 Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 14,000 14,000 - - Stock Option (Right to Buy)
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 5,000 21,547 (0%) 0% 0 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2017 12,000 12,000 - - Stock Option (Right to Buy)
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. 01 May 2017 134 44,402 (0%) 0% 18.6 2,487 Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. 01 May 2017 909 179,600 (3%) 0% 18.6 16,871 Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. 01 May 2017 503 16,547 (0%) 0% 18.6 9,336 Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. 01 May 2017 311 25,411 (0%) 0% 18.6 5,772 Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 20.56 per share. 09 Mar 2017 10,513 17,050 (0%) 0% 20.6 216,147 Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Dec 2016 3,461 27,563 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Dec 2016 1,630 31,024 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 1,000 110,481 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 500 108,381 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 1,000 109,481 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Nov 2016 1,000 26,983 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 701 111,481 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 100 108,881 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 800 112,182 - - Common Stock, $.005 Par Value
Fred J. Weinert None Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Nov 2016 500 108,981 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Nov 2016 200 200 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2016 3,000 25,722 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Nov 2016 5,000 32,654 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Nov 2016 5,000 37,654 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 596 44,536 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 779 45,132 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 1,784 181,888 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 1,379 180,509 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 911 43,428 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 774 42,654 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 330 28,722 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 23 May 2016 377 29,052 - - Common Stock, $.005 Par Value
A. Clinton Allen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 13,000 13,000 - - Stock Option (Right to Buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 13,000 13,000 - - Stock Option (Right to Buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 1,800 27,983 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 4,300 45,662 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 7,500 7,500 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 42,000 42,000 - - Stock Option (Right to Buy)
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 13,000 13,000 - - Stock Option (Right to Buy)
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 6,500 44,339 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 11,000 11,000 - - Stock Option (Right to Buy)
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2016 415 45,911 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2016 1,054 183,672 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2016 565 37,839 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2016 295 29,429 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 May 2016 146 46,326 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 May 2016 921 184,726 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 May 2016 709 38,404 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 May 2016 327 29,724 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 02 Mar 2016 700 41,362 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Feb 2016 400 40,662 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Feb 2016 600 40,262 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Feb 2016 700 39,362 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Feb 2016 300 39,662 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Feb 2016 400 38,662 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Feb 2016 600 38,262 - - Common Stock, $.005 Par Value
Harry F. Connick None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Feb 2016 1,000 37,662 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Feb 2016 4,507 46,472 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Dec 2015 200 27,983 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Dec 2015 200 27,783 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Dec 2015 200 27,583 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Dec 2015 400 27,183 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Dec 2015 1,000 26,183 - - Common Stock, $.005 Par Value
A. Clinton Allen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2015 1,000 1,280 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2015 22,000 22,000 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2015 22,000 22,000 - - Stock Option (Right to Buy)
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2015 2,000 2,000 - - Stock Option (Right to Buy)
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Sep 2015 1,000 184,647 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Sep 2015 1,000 185,647 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Sep 2015 3,000 30,051 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jun 2015 1,601 43,201 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jun 2015 1,236 41,965 - - Common Stock, $.005 Par Value
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 18,650 0 - - 2000 Stock Option Plan
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 18,650 46,527 - - Common Stock, $.005 Par Value
Fred J. Weinert None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 18,344 28,183 - - Common Stock, $.005 Par Value
Harry F. Connick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 5,150 0 - - 2000 Stock Option Plan
Harry F. Connick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 5,150 41,727 - - Common Stock, $.005 Par Value
Harry F. Connick None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 5,065 36,662 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 783 46,087 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 596 45,491 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 689 44,802 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 4,866 0 - - 2000 Stock Option Plan
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 72,434 0 - - 2000 Stock Option Plan
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 4,866 192,342 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 72,434 264,776 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 71,246 193,530 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 386 193,144 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 4,786 188,358 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 1,787 186,571 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 1,381 185,190 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 1,543 183,647 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 10,350 0 - - 2000 Stock Option Plan
Walter S. Tomenson None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2015 10,350 41,579 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 10,180 31,399 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 936 40,657 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 795 39,862 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 749 39,113 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 345 27,601 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 306 24,295 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2015 400 26,895 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2015 394 46,870 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2015 1,056 187,476 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2015 471 41,593 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 May 2015 311 27,946 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 5,100 27,877 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 3,500 36,578 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 1,500 47,264 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 11,500 188,532 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 3,500 31,229 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 6,500 42,064 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 3,300 28,257 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 21 Nov 2014 1,000 22,777 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2014 1,790 178,957 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2014 1,383 177,574 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 May 2014 1,546 176,028 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 3,225 23,777 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 3,225 37,402 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 4,300 45,149 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 13,000 180,747 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 3,225 27,729 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 7,100 35,564 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 3,300 24,671 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 May 2014 1,115 40,849 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 May 2014 2,441 167,747 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 05 May 2014 496 28,464 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2014 10,250 0 - - 2000 Stock Option Plan
Michael I. Schaffer VP of Laboratory Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2014 6,350 0 - - 2000 Stock Option Plan
Michael I. Schaffer VP of Laboratory Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2014 10,250 48,945 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 Mar 2014 8,154 40,791 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 Mar 2014 735 40,056 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2014 6,350 46,406 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 Mar 2014 5,051 41,355 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2014 5,913 0 - - Incentive Stock Option
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2014 4,087 0 - - Non-qualified Stock Option
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2014 5,913 173,206 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 13 Feb 2014 3,947 169,259 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2014 4,087 173,346 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 13 Feb 2014 2,728 170,618 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 13 Feb 2014 430 170,188 - - Common Stock, $.005 Par Value
Harry F. Connick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 5,150 0 - - Nonqualified Stock Option
Harry F. Connick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 5,150 31,200 - - Common Stock, $.005 Par Value
Harry F. Connick None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Feb 2014 3,803 27,397 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 3,000 0 - - 2000 Stock Option Plan
Michael I. Schaffer VP of Laboratory Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 3,000 40,945 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Feb 2014 2,250 38,695 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 5,150 0 - - 2000 Stock Option Plan
Walter S. Tomenson None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 5,150 28,307 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Feb 2014 3,803 24,504 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 15 Nov 2013 850 14,552 - - Common Stock, $.005 Par Value
Harry F. Connick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2013 6,438 0 - - Nonqualified Stock Option
Harry F. Connick None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2013 6,438 30,100 - - Common Stock, $.005 Par Value
Harry F. Connick None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 03 Sep 2013 4,050 26,050 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 688 38,724 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 779 37,945 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 1,793 167,293 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 1,548 169,086 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 608 29,624 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 664 28,960 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 445 21,750 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 28 May 2013 379 21,371 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 4,000 18,700 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 4,000 23,662 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 6,500 39,412 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 17,000 170,634 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 4,000 23,157 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 8,500 30,232 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2013 3,500 22,195 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 Apr 2013 1,177 32,912 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 Apr 2013 2,421 153,634 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 Apr 2013 768 21,732 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2013 5,150 23,150 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2013 5,150 0 - - Nonqualified Stock Option
Walter S. Tomenson None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 14 Mar 2013 3,993 19,157 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Nov 2012 1,024 24,476 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Nov 2012 1,676 22,500 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Nov 2012 200 24,176 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Nov 2012 100 24,376 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2012 470 34,089 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Jun 2012 2,500 18,695 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 24 May 2012 608 33,619 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 24 May 2012 1,494 156,055 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 24 May 2012 400 16,195 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 4,000 14,700 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 4,000 19,662 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 8,500 34,227 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 22,000 158,549 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 4,000 18,000 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 10,000 25,500 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2012 4,000 16,595 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 May 2012 365 25,727 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 May 2012 1,179 131,408 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2012 973 25,561 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2012 2,359 137,728 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 3,700 37,552 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 3,700 14,000 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 7,500 26,534 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 19,000 140,087 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 3,700 14,000 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 8,000 15,500 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 4,700 6,700 - - Common Stock, $.005 Par Value
Neil Lerner VP - Finance Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2011 5,895 12,595 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 16 May 2011 413 19,034 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 16 May 2011 1,191 121,087 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2011 409 19,447 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2011 1,032 122,278 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2011 973 19,856 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 07 Apr 2011 2,359 123,310 - - Common Stock, $.005 Par Value
Neil Lerner Vice President and Controller Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Mar 2011 2,000 2,000 - - Common Stock, $.005 Par Value
H. Wayne Huizenga Other Gift of securities by or to the insider at price $ 0.00 per share. 21 Dec 2010 105,000 290,866 - - Common Stock
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2010 1,000 88,832 - - Common Stock, $.005 Par Value
Fred J. Weinert None Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2010 1,000 1,000 - - Common Stock, $.005 Par Value
Compton D Jonathan Vice President - Marketing Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 May 2010 82 7,583 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2010 324 21,437 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2010 243 21,194 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2010 365 20,829 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2010 472 17,394 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2010 393 17,001 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 5,000 33,852 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 5,000 10,300 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 12,000 21,761 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 30,000 128,657 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 5,000 10,300 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 9,000 17,866 - - Common Stock, $.005 Par Value
Raymond J. Ruddy Vice President/Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 2,000 2,921 - - Common Stock, $.005 Par Value
Compton D Jonathan Vice President - Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 6,000 7,665 - - Common Stock, $.005 Par Value
James V. Dyke Vice President - Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2010 7,500 7,500 - - Common Stock, $.005 Par Value
Raymond J. Ruddy Vice President/Controller Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 Dec 2009 79 921 - - Common Stock, $.005 Par Value
Compton D Jonathan Vice President - Marketing Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 Dec 2009 53 1,665 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 May 2009 365 9,761 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 May 2009 1,179 98,657 - - Common Stock, $.005 Par Value
Compton D Jonathan Vice President - Marketing Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 May 2009 82 1,718 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 May 2009 568 10,126 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 May 2009 1,808 99,836 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 May 2009 865 8,866 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2009 1,022 127,635 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2009 786 126,849 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 10 May 2009 1,180 125,669 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Mar 2009 100 100,744 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Mar 2009 900 101,644 - - Common Stock, $.005 Par Value
Compton D Jonathan Vice President - Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2008 800 1,800 - - Common Stock, $.005 Par Value
Raymond J. Ruddy Vice President/Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Oct 2008 1,000 1,000 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2008 2,561 8,979 - - Stock Option (Right to Buy)
William R. Thistle Sr. VP and Gen. Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2008 2,561 12,295 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 12 Jun 2008 151 12,141 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Jun 2008 2,410 9,731 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2008 2,000 26,150 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2008 2,000 5,300 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2008 4,500 10,694 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2008 15,000 100,644 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2008 2,000 5,300 - - Common Stock, $.005 Par Value
Jennifer Chmieleski Vice President, Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2008 1,200 1,200 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 12 May 2008 568 6,194 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 12 May 2008 1,826 85,644 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 12 May 2008 873 9,731 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 May 2008 957 11,561 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 May 2008 57 11,504 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 May 2008 900 10,604 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 May 2008 957 11,543 - - Stock Option (Right to Buy)
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 May 2007 5,150 0 - - Stock Option (Right to Buy)
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 May 2007 5,150 89,832 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 25 May 2007 238 6,762 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 25 May 2007 793 87,470 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 25 May 2007 396 10,604 - - Common Stock, $.005 Par Value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2007 2,000 24,150 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2007 2,000 3,300 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2007 4,000 7,000 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2007 13,000 88,263 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2007 2,000 3,300 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2007 6,000 11,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2007 9,750 0 - - Stock Option (Right to Buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2007 9,750 11,750 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Mar 2007 1,000 10,750 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Mar 2007 1,000 9,750 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Mar 2007 5,250 4,500 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Mar 2007 2,500 2,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2007 3,350 10,750 - - Stock Option (Right to Buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2007 1,000 9,750 - - Stock Option (Right to Buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2007 3,350 5,350 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2007 1,000 4,350 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2007 1,350 3,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2007 500 2,500 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2007 500 2,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2007 1,000 3,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2007 500 2,500 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2007 500 2,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2007 3,000 5,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2007 2,500 2,500 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2007 500 2,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2007 3,000 14,100 - - Stock Option (Right to Buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2007 3,000 5,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Feb 2007 2,000 3,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Feb 2007 700 2,300 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Feb 2007 300 2,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2007 2,500 4,500 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Feb 2007 2,500 2,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2007 2,500 0 - - Stock Option (Right to Buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2007 3,000 0 - - Stock Option (Right to Buy)
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2006 5,150 84,682 - - Common Stock, $.005 par value
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2006 5,150 0 - - Stock Option (right to buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 1,300 22,150 - - Common Stock, $.005 Par Value
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 1,300 1,300 - - Common Stock, $.005 Par Value
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 3,000 3,000 - - Common Stock, $.005 Par Value
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 10,000 75,263 - - Common Stock, $.005 Par Value
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 1,300 1,300 - - Common Stock, $.005 Par Value
William R. Thistle Sr. VP and Gen. Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 5,000 5,000 - - Common Stock, $.005 Par Value
Peter C. Monson VP, Treas., CFO & Asst. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2006 2,000 2,000 - - Common Stock, $.005 Par Value
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2005 5,150 0 - - Stock Option (right to buy)
Fred J. Weinert None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2005 5,150 79,532 - - Common Stock, $.005 par value
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 18,650 18,650 - - Stock Option (right to buy)
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 5,150 5,150 - - Stock Option (right to buy)
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 16,600 16,600 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 77,300 77,300 - - Stock Option (right to buy)
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 10,350 10,350 - - Stock Option (right to buy)
William Dausey Vice President of Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 10,000 10,000 - - Stock Option (right to buy)
William R. Thistle Sr. VP and Gen. Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 40,600 40,600 - - Stock Option (right to buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2005 17,100 17,100 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2005 10,300 0 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2005 10,300 74,821 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Apr 2005 5,200 69,621 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 04 Apr 2005 4,358 65,263 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2005 1,600 10,300 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2005 1,600 66,121 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2005 1,600 64,521 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Mar 2005 18,700 83,221 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Mar 2005 11,000 72,221 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Mar 2005 300 71,921 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Mar 2005 4,400 67,521 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Mar 2005 3,000 64,521 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Mar 2005 18,700 11,900 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2005 8,025 72,546 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Mar 2005 8,025 64,521 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2005 8,025 30,600 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2005 8,025 72,546 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Mar 2005 8,025 64,521 - - Common Stock, $.005 par value
Raymond C. Kubacki Director, Chairman, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2005 8,025 30,600 - - Stock Option (right to buy)
Christoph T Richard Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Feb 2005 25,419 54,856 - - Common Stock
Christoph T Richard Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Feb 2005 5,600 363,300 - - Common Stock
Christoph T Richard Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Feb 2005 9,900 33,800 - - Common Stock
Michael I. Schaffer VP of Laboratory Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 3,000 3,000 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and Pres. Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 5,913 5,913 - - Stock Option (right to buy)
Raymond C. Kubacki Director, Chairman, CEO and Pres. Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 4,087 4,087 - - Stock Option (right to buy)
William Dausey Vice President of Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 2,506 2,506 - - Stock Option (right to buy)
William Dausey Vice President of Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 494 494 - - Stock Option (right to buy)
William R. Thistle Sr. VP and Gen. Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 1,183 1,183 - - Stock Option (right to buy)
William R. Thistle Sr. VP and Gen. Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 3,817 3,817 - - Stock Option (right to buy)
Peter C. Monson VP, Treas., CFO & Asst. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2004 3,000 3,000 - - Stock Option (right to buy)
Fred J. Weinert None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2004 5,150 5,150 - - Stock Option (right to buy)
Harry F. Connick None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2004 5,150 5,150 - - Stock Option (right to buy)
Walter S. Tomenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2004 5,150 5,150 - - Stock Option (right to buy)
Christoph T Richard Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jan 2004 50,000 56,600 - - Common Stock
A. Clinton Allen Director, Chairman Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2003 5,000 124,173 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters